Division of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu, 41944, South Korea.
Clinical Research Center for End Stage Renal Disease, Daegu, South Korea.
Sci Rep. 2023 Apr 13;13(1):6049. doi: 10.1038/s41598-023-33216-w.
Optimal preparation is recommended for patients with advanced chronic kidney disease to minimize complications during dialysis initiation. This study evaluated the effects of planned dialysis initiation on survival in patients undergoing incident hemodialysis and peritoneal dialysis. Patients newly diagnosed with end-stage kidney disease who started dialysis were enrolled in a multicenter prospective cohort study in Korea. Planned dialysis was defined as dialysis therapy initiated with permanent access and maintenance of the initial dialysis modality. A total of 2892 patients were followed up for a mean duration of 71.9 ± 36.7 months and 1280 (44.3%) patients initiated planned dialysis. The planned dialysis group showed lower mortality than the unplanned dialysis group during the 1st and 2nd years after dialysis initiation (1st year: adjusted hazard ratio [aHR] 0.51; 95% confidence interval [CI] 0.37-0.72; P < 0.001; 2nd year: aHR 0.71; 95% CI 0.52-0.98, P = 0.037). However, 2 years after dialysis initiation, mortality did not differ between the groups. Planned dialysis showed a better early survival rate in hemodialysis patients, but not in peritoneal dialysis patients. Particularly, infection-related mortality was reduced only in patients undergoing hemodialysis with planned dialysis initiation. Planned dialysis has survival benefits over unplanned dialysis in the first 2 years after dialysis initiation, especially in patients undergoing hemodialysis. It improved infection-related mortality during the early dialysis period.
建议对患有晚期慢性肾脏病的患者进行最佳准备,以最大限度地减少透析开始时的并发症。本研究评估了计划透析启动对接受新发性血液透析和腹膜透析患者生存的影响。在韩国的一项多中心前瞻性队列研究中,招募了新诊断为终末期肾病且开始透析的患者。计划透析定义为使用永久性通路开始透析治疗,并维持初始透析方式。共有 2892 名患者接受了平均 71.9±36.7 个月的随访,其中 1280 名(44.3%)患者开始了计划透析。在透析开始后的第 1 年和第 2 年,计划透析组的死亡率低于非计划透析组(第 1 年:调整后的危险比 [aHR] 0.51;95%置信区间 [CI] 0.37-0.72;P<0.001;第 2 年:aHR 0.71;95% CI 0.52-0.98,P=0.037)。然而,在透析开始后 2 年,两组之间的死亡率没有差异。计划透析在血液透析患者中显示出更好的早期生存率,但在腹膜透析患者中则不然。特别是,计划透析启动仅可降低与感染相关的死亡率。在透析开始后的前 2 年,计划透析较非计划透析具有生存优势,尤其是在血液透析患者中。它改善了早期透析期间与感染相关的死亡率。